Miyir-qabka (Antispasmodics) ma daaweyn karaa IBS?

Sidee baa daroogooyinka loo bartaa murqaha si loo yareeyo calaamadaha

Xarumaha Xakamaynta iyo Ka Hortagga Cudurrada ayaa qiyaasaya in inta badan 1.3 qof oo Maraykan ah ay qabaan calaamadaha xanuunka mindhicirka (IBS) , oo ah xanuunka caloosha ee jidhka ee xanuunka caloosha iyo isbeddelka caadada mindhicirka.

Maadaama cilmi-baarayaashu aysan weli aqoonsan sababta keentay IBS, daaweyntu waxay ugu horreyntii loola jeedaa inay cirib tirto calaamadaha xanuunka (oo ay ku jiraan xanuunka caloosha, casiraad, shuban, shuban, iyo caloosha).

Daawooyinka kala duwan ee loo isticmaalo daawaynta IBS, antispasmodics ayaa cadeeyeen mid dhexdhexaad ah oo wax ku ool ah si loo yareeyo calaamadaha iyadoo la beegsanayo iyo nasinta muruqyada siman ee habka dheef-shiidka. Maadaama ay calaamaduhu u muuqdaan kuwo aad u qoto dheer marka qofku cuno, daroogada ayaa sida caadiga ah loo qaataa 30 ilaa 60 daqiiqo cuntada ka hor.

Waxaa jira noocyo kala duwan oo antispasmodic loo isticmaalo si loo daaweeyo IBS, oo ay ku jiraan:

Anticholinergics

Anticholinergics waa nooc ka mid ah daroogada loogu talagalay in lagu xakameeyo acetylcholine. Tani waa kiimikada ay soo saartey jirka kaas oo wax ka qabanaya nidaamka dareenka madaxbannaan (qayb ka mid ah nidaamka dareenka ee la xiriira shaqooyinka aan qasabka ahayn). By joojinta receptor acetylcholine ee habka dheef-shiidka, anticholinergics hoos u dhigi kartaa darnaanta muruqyada muruqyada iyo kororka xabka .

Nasiib darro, daroogadu waxay sidoo kale saameyn kartaa nidaamyada kale ee unugyada , waxay dhalinaysaa saameynaha daaweyneed oo ka duwan aragtida cakiran iyo caloosha oo ku yaraata kaadida iyo madax-wareer.

Sababtoo ah khatarta caloosha, anticholinergics ayaa si fiican loogu isticmaalaa xaaladaha shubanka- IBS-da ( IBS-D ) halkii ay ka ahaan lahayd calool-fadhiga IBS ( IBS-C ). Dib-u-ceshadeynta Gastric sidoo kale waa saameyn caadi ah.

Noocyada ugu badan ee loo yaqaan anticholinergics waxaa ka mid ah:

Mebeverine

Mebeverinis waa spasmolyticic musculotropic kaas oo u shaqeeya anticholinergics laakiin ma laha saameynaha asetylcholine. Dareen-celinta xasaasiyadeed ayaa laga soo sheegay qaar ka mid ah, badanaa oo ah qaab-firfircooni-darro hooseeya.

Mebeverinin waxaa caadi ahaan loo qoraa dadka IBS waxaana lagu heli karaa magacyo kala duwan oo kala duwan oo ay ka mid yihiin Colofac, Duspamen, iyo Duspatalin.

Saliida laftirka

Saliideedka qallalan waa miisaan daboolaya oo ka kooban miisaanka, oo ah walax u muuqda in uu leeyahay saamayn nasasho ah oo ku saabsan murqaha jilicsan.

Dib-u-eegista cilmi baarista ee Jaamacadda California, San Diego ayaa soo gabagabeysay in dadka qaba calaamadaha IBS ay ku dhawaad ​​saddex jeer ka badan tahay inay u suurtogasho in lagu helo saliid qalliin leh marka la barbardhigo kuwa bixiya sanduuqa.

Iyadoo loo tixgelinayo inay tahay mid ammaan u ah isticmaalka gaaban, saliidda qaliinka loo yaqaan 'peppermint oil' ayaa loo yaqaan sababta muraayadda (xaalad laga yaabo in laga fogaado isticmaalka kaabayaasha xididka leh ). U hubso inaad la tashato dhakhtarkaaga ka hor inta aadan qaadan saliida laf-dhabarta ama wixii kale ee ka-soo-kabashada ah.

Saliidda qashinka ah waa in loo isticmaalaa taxadar leh dadka qaba mantaroolka, hernia hernia, dhaawaca beerka oo daran, barar xajmeed, ama xakameyn xiidmaha.

Isbedelada Cuntada

Marka laga soo tago daawooyinka antispasmodic, isbedelka cuntada ayaa sidoo kale si weyn u wanaajin kara calaamadaha IBS.

Iyada oo ku xiran noocyada aad la kulantay, waxaa laga yaabaa inaad rabto inaad:

> Ilo:

> Xarumaha Xakamaynta iyo Ka Hortagga Cudurrada. "Epidemiology of IBD." Atlanta, Georgia; updated March 31, 2015.

> Ford, A ;; Moyyadde, P .; Lacy, B. et.al. "Jaamacadda American College of Gastroenterology Sawir ku Saabsan Maareynta Xanuunka Calaamadaha Saxarada iyo Xanuunka Idiopathic Chronic" Amer J Gastroenterol. 2014; 109: S2-S26. DOI: 10.1038 / ajg.12.187.

> Khanna, A .; MacDonald, J; iyo Levesque, B. "Saliida saliidda ee daaweynta cilladda mindhicirrada xanuunka leh: dib u eegis nidaamsan iyo falanqeyn mala-awaal." J Clin Gastroenterol. 2014; 48 (6): 505-12. DOI: 10.1097 / MCG.0b013e3182a88357.